| Income Statement |
| Total Revenue | 2.79M |
|
| Revenues (USD) | 2.79M |
| Cost of Revenue | 1.46M |
| Gross Profit | 1.33M |
| Operating Expenses | 8.42M |
| Research and Development Expense | 4.43M |
| Selling, General and Administrative Expense | 3.99M |
| Operating Income | -7.09M |
| Net Income | -7.03M |
| Net Income Common Stock | -7.03M |
| Net Income Common Stock (USD) | -7.03M |
| Consolidated Income | -7.03M |
| Earnings per Basic Share | -0.15 |
| Earnings per Basic Share (USD) | -0.15 |
| Earnings per Diluted Share | -0.15 |
| Earning Before Interest & Taxes (EBIT) | -7.03M |
| Earning Before Interest & Taxes (USD) | -7.03M |
| Weighted Average Shares | 47.46M |
| Weighted Average Shares Diluted | 47.46M |
| Balance Sheet |
| Cash and Equivalents | 17.93M |
| Cash and Equivalents (USD) | 17.93M |
| Trade and Non-Trade Receivables | 1.93M |
| Current Assets | 24.50M |
| Property, Plant & Equipment Net | 1.37M |
| Total Assets | 25.95M |
| Debt Current | 426.00K |
| Total Debt | 788.00K |
| Current Liabilities | 5.36M |
| Debt Non-Current | 362.00K |
| Total Liabilities | 5.73M |
| Accumulated Retained Earnings (Deficit) | -162.70M |
| Shareholders Equity | 20.22M |
| Shareholders Equity (USD) | 20.22M |
| Assets Non-Current | 1.45M |
| Total Debt (USD) | 788.00K |
| Deferred Revenue | 84.00K |
| Inventory | 3.49M |
| Liabilities Non-Current | 362.00K |
| Trade and Non-Trade Payables | 1.36M |
| Cash Flow |
| Depreciation, Amortization & Accretion | 150.00K |
| Net Cash Flow from Financing | 13.95M |
| Net Cash Flow / Change in Cash & Cash Equivalents | 7.84M |
| Capital Expenditure | -48.00K |
| Issuance (Purchase) of Equity Shares | 14.04M |
| Net Cash Flow from Investing | -48.00K |
| Net Cash Flow from Operations | -6.07M |
| Effect of Exchange Rate Changes on Cash | -17.00K |
| Share Based Compensation | 334.00K |